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Structure of the Predominant Protein
Arginine Methyltransferase PRMT1
and Analysis of Its Binding to Substrate Peptides
have been reported so far: PRMT1, PRMT2, PRMT3,
CARM1/PRMT4 [12–17], JBP1/PRMT5 [18, 19], and
PRMT6 [20]. At least eight PRMTs are present in the
completed Drosophila melanogaster genome (X.Z., un-
published observation). The presence of a large number
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of PRMTs may signify the diverse roles PRMTs can play.
How does arginine methylation affect protein func-
tion? There is some evidence that arginine methylationSummary
can affect a protein’s affinity for RNA [21]. However, at
least in the case of Hrp1p binding to its specific, high-PRMT1 is the predominant type I protein arginine
affinity RNA target, arginine methylation does not seemmethyltransferase in mammals and highly conserved
to affect the strength of nucleic acid binding [22, 23].among all eukaryotes. It is essential for early postim-
More recent evidence suggests that arginine methyla-plantation development in mouse. Here we describe
tion affects the interaction of the substrate proteins withthe crystal structure of rat PRMT1 in complex with the
other proteins [6, 24, 25] as well as their subcellularreaction product AdoHcy and a 19 residue substrate
localization in yeast and mammalian cells [26–29]. Argi-peptide containing three arginines. The results reveal a
nine methylation has been implicated in receptor-medi-two-domain structure—an AdoMet binding domain and
ated signaling [5, 12, 17, 30], in some cases througha barrel-like domain—with the active site pocket lo-
methylation of a transcription factor or cofactor [6, 25].cated between the two domains. Mutagenesis studies
Histone arginine methylation is a component of the “his-confirmed that two active site glutamates are essential
tone code” that directs a variety of processes involvingfor enzymatic activity, and that dimerization of PRMT1
chromatin [31, 32]. For example, methylation of Arg3is essential for AdoMet binding. Three peptide binding
of histone H4 by PRMT1 facilitates H4 acetylation andchannels are identified: two are between the two do-
enhances transcription activation by nuclear hormonemains, and the third is on the surface perpendicular
receptors in a synergistic fashion to CARM1 [8, 25, 33, 34].to the strands forming the  barrel.
PRMT1 is the predominant type I PRMT in mammalian
cells, accounting for 85% of cellular PRMT activity [35,
Introduction 36]. It is essential for early postimplantation develop-
ment, as shown by the embryonic lethality of mouse
Protein arginine methylation is a common posttransla- PRMT1/ mutants [36]. PRMT1 is expressed at detecti-
tional modification in eukaryotes. The major type of pro- ble levels in all tissues examined [15–17, 36] (the highest
tein arginine (R ) methyltransferase (PRMT), type I, trans- is in developing neural structure in embryos [36]), and
fers the methyl group from S-adenosyl-L-methionine PRMT1 has been implicated in neuronal differentiation
(AdoMet) to the guanidino group of arginines in protein [37]. Besides the numerous substrates that interact with
substrates, resulting in monomethylarginine and asym- PRMT1, other proteins also bind to PRMT1. For exam-
metric dimethylarginine in substrate proteins [1]. The ple, antiproliferative protein interferon receptor IFNAR-1
best known substrates for type I PRMT are RNA binding [38] and BTG/TOB proteins [17, 39] bind PRMT1 and
proteins involved in various aspects of RNA processing modulate its activity, and p160 nuclear hormone coacti-
and/or transport, such as hnRNPs, fibrillarin, nucleolin vators bind PRMT1 and recruit it to its substrate such
[2], and poly(A) binding protein II [3]. More recently, a as histone H4 [33].
growing number of other proteins have been found to be PRMT1 gene is found in all eukaryotes tested and is
substrates of PRMT1, including high molecular weight highly conserved (Figure 1A). The sequence identity is
fibroblast growth factor 2 (HMW FGF-2, a nuclear growth over 90% among mammals, zebrafish, and Xenopus,
factor [4]), interleukin enhancer binding factor 3 (ILF3) and about 50% even between human and S. cerevisiae.
[5], STAT1, a transcription factor activated by extracellu- There appears to be another gene closely related to
lar signals [6], and histone H4 [7, 8]. Most PRMT1 sub- PRMT1 genes both in A. thaliana and in human
strates contain glycine- and arginine-rich (GAR) se- (HRMT1L3, XP_077339, on chromosome 12p13), which
quences that include multiple arginines in RGG or RXR in each case shares 80% amino acid identity with
contexts [2–4]. However, increasing numbers of sub- PRMT1. Except for the N termini, the two genes have
strates lacking GAR domain are being discovered [9], identical genomic structure: each pair has eight introns
including STAT1 and histone H4, which contain no other inserted at identical positions, and the locations of seven
arginines near the methylation target. of those introns are also shared between human and A.
PRMT genes are present in eukaryotes from fungi to thaliana. No function for this PRMT1-like gene has been
plants and animals. Though Saccharomyces cerevisiae reported. Like S. cerevisiae, C. elegans and S. pombe
has only one PRMT homolog [10, 11], multiple genes have only one copy of PRMT1 and share some of the
have been found in plants and animals. For example,
six very similar paralogous mammalian PRMT genes
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Figure 1. Members of the PRMT1 Family
(A) Structure-based sequence alignment of rat PRMT1, PRMT3 [43], and yeast RMT1 [44]. Letters (A–Z) for helices and numbers (1–15) for
strands indicate the secondary structure elements of rat PRMT1 or PRMT3; residue numbering is shown above or below the sequences. The
color coding is red for the N terminus including helix Y (residues 41–51), green for the AdoMet binding domain (residues 52–176), yellow for
the  barrel structure (residues 177–187 and 217–352), and blue for the dimerization arm (residues 188–216). For rat PRMT1, the amino acids
highlighted (white against black) are invariant among PRMT1s from various organisms: rat PRMT1 (GenBank accession number NP_077339),
human PRMT1-v2 (modified from CAA71764), PRMT1-like (also called HMT1L3, XP_006990), C. elegans PRMT1 (CAB54335), D. melanogaster
PRMT1 (AAF54556), A. thaliana PRMT1 (CAB79709), A. thaliana PRMT1-like (AAC62148), S. pombe PRMT1 (CAB63498), and S. cerevisiae
RMT1 (585608). The Xenopus and zebrafish PRMT1 sequences were assembled from ESTs with sequences highly similar to that of rat PRMT1.
The N-terminal sequences shown with a strikethrough are not observed in the crystal structures, presumably due to being highly disordered
in the crystals. The asterisks above the sequence indicate residues important for cofactor binding (see Figure 4A) and/or catalysis (see Figure 7A).
(B) N-terminal splicing variants of human PRMT1.
splicing sites used by human and A. thaliana. D. melano- ity [40]. By comparing available human PRMT1 ESTs
with the genomic sequence (AC011495.1), at least threegaster encodes four to six PRMT proteins of similar
size, but of these only DmPRMT1 (AAF54556) has a high additional N-terminal splicing variants (v4–v6) can be
identified (Figure 1B). In Xenopus, at least two versionspercentage identity with the mammalian PRMT1 (65%
vs. 15%–35% for the others; X.Z., unpublished obser- corresponding to the mammalian v1 and v2 can also be
found in the available EST sequences (BE025764 for v1;vation).
The N terminus is the least conserved region among BE025704 for v2).
The vast majority of human and mouse ESTs representPRMT1s (Figure 1A). Three splicing variants (v1–v3) at
the N terminus have been documented in human [15], splicing version 1, which encodes a protein of 353 amino
acids. The wild-type PRMT1 we used is the ratproducing mRNAs coding proteins between 353–371
amino acids long slightly different at their N termini [15, PRMT1v1, which is identical to the mouse protein and
differs from the human enzyme at only one position36]. Variants v1 and v2 are also found in mouse, and v1
is found in rat. The two splicing variants of mouse are (H161 is Y in human). The previously reported human
version 1 sequences (AAF62895 and CAA71765) lackboth expressed in all the tissues examined [36]. It has
been reported that the 353 amino acid v1 and 371 amino the first ten amino acids of the rat sequence. However,
close examination of the genomic sequence of humanacid v2 mouse PRMT1 have different substrate specific-
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Figure 2. Activity of PRMT1 Proteins
(A) Reactions (20 l) contained 4 or 8 M of purified hnRNP A1 (130 or 260 g/ml), 40 M [methyl-3H]AdoMet (0.5 Ci), and the indicated
amount of PRMT1 in 100 mM Tris (pH 8.0), 200 mM NaCl, 2 mM EDTA, and 1 mM dithiothreitol. After incubating at 37C for 15 min, the
samples were analyzed by SDS-PAGE. The upper panel shows the Coomassie-stained gel of total PRMT1 and hnRNP A1, while the lower
panel shows the image resulting from fluorography. Various amounts of wild-type PRMT1 (lanes 3–5, 11–15, and 21–23) were used so that
the relative activity of mutant PRMTs could be estimated.
(B) Methylation of peptides R3 or R1 (RGG) and competition by hnRNP A1. Reaction conditions are identical to Figure 2A and include 10
g/ml of PRMT1, 5 M of hnRNP A1 and/or various amounts of peptides as indicated.
(C) Time course of AdoMet crosslinking of wild-type PRMT1 and ARM mutant.
(D) AdoMet crosslinking of various PRMTs and mutants. The samples were treated with UV for 1 hr. Controls were used: yRMT1 (yeast RMT1),
PRMT3 (full-length rat PRMT3), PRMT3200 (rat PRMT3 conserved core), and HhaI (DNA cytosine methyltransferase).
PRMT1 (AC011495.1) and of many ESTs (e.g., (MGHHHHHH). The enzyme was very active using either
BE882188) suggests the presence of an additional exon hnRNP A1 (Figure 2A) or a 19 residue peptide (R3; Figure
that would add the same ten N-terminal amino acids to 2B) as substrate. Limited proteolysis using V8 or elas-
the human sequence. Here we present the structures tase resulted in very stable fragments lacking the first
of PRMT1-AdoHcy and its complex with peptide sub- 10 or 13 residues, respectively (data not shown). His tag
strates, solved by molecular replacement using PRMT3 fusion proteins corresponding to these stable fragments
core structure [43]. These structures reveal active site (named M11 or S14) have similar enzymatic activity (Fig-
residues, confirmed by mutagenesis studies, and indi- ure 2A, lanes 1–7) and form similar sizes of oligomers
cate the locations of peptide binding channels. The as the full length (Table 1). The deletions crystallized
oligomerization behavior of PRMT1, in solution and in more readily than the full-length protein, and structures
crystal, is also discussed in comparison with the yeast containing these two deletions or a full-length PRMT1
RMT1 structure [44]. containing an E153Q mutation at the active site (see
below) were determined (Table 2). All crystals contained
the methylation product AdoHcy, and S14 and full-Results and Discussion
length E153Q also contained substrate peptide R3 (19
amino acids) or R1 (10 amino acids), respectively. TheyOverall Structure of PRMT1
belong to the primitive tetragonal space group P4122,We expressed the rat PRMT1v1 (353 amino acids) as
a fusion protein containing a short N-terminal His tag though the cell dimensions vary slightly from crystal to
Structure
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Table 1. Summary of Characterization of PRMT1 Mutants
DLS size (kDa)
Activity
Plasmid Protein Expression Solubility GF Size (kDa) AdoHcy AdoHcy (hnRNP A1)
pXC168 WT   320 780 440 100%
pXC246 WT (no tag)   400 Not done Not done 100%
pXC247 M11 (no tag)   250 360 330 100%
pXC248 M11   250 405 280 100%
pXC249 S14   250 2 K 400 100%
pXC250 S38   250 240 240 Not detected
pXC256 L49  
pXC252 E153Q   250 370 330 Not detected
pXC258 E153D   300 450–3 K 320–400 0.03%
pXC255 E144Q   Void 2 K 2 K 0.03%
pXC257 E144D   600 970 620 10%
pXC335 M11 C254S   250 Not done 375 100%
pXC336 M11 ARM  / 37 Not done Not done Not detected
The size of the oligomer is affected by the presence of cofactor AdoMet or product AdoHcy. In the absence of added AdoMet or AdoHcy,
the protein eluted from gel filtration (GF) column S300HR (Pharmacia) as an asymmetrical peak with a long trailing tail, with the peak
corresponding to a protein of about 500 kDa. When the protein was preincubated with AdoHcy, it eluted as a 320 kDa protein with a symmetrical
elution profile. This is very similar to the endogenous PRMT1 in rat or HeLa cell extract, which eluted as a 330 kDa complex [8, 16]. Dynamic
light scattering (DLS) measurement suggested that the size of PRMT1 oligomer is also influenced by temperature and protein concentration.
The oligomer size has a lower limit of about 300 kDa but can go beyond 1000 kDa at lower temperature and higher protein concentration.
crystal (Table 2). In all three structures only the residues negatively charged C-terminal carboxyl group has an
important role for binding positively charged substrateafter amino acid 40 were observed, suggesting a disor-
dered amino terminus. There are few significant struc- and/or for catalysis.
tural differences among the three protein structures,
and we describe primarily the ternary structure of S14- Cofactor Binding
The cofactor product, AdoHcy, which was present dur-AdoHcy-R3 unless otherwise indicated.
The overall monomeric structure of PRMT1 can be ing crystal growth (see Experimental Procedures), is ob-
served in a deep pocket on the carboxyl ends of thedivided into four parts (Figure 3A): N-terminal (red), Ado-
Met binding (green),  barrel (yellow), and dimerization parallel strands 1–5 (Figure 3A), surrounded by resi-
dues that are highly conserved in the PRMT family (Fig-arm (light blue). The AdoMet binding domain has the
consensus fold conserved in other AdoMet-dependent ure 4A). The interactions can be grouped according to
the three moieties of AdoHcy: (1) the Gly-rich loop (G78methyltransferases [41, 42], whereas thebarrel domain
is unique to the PRMT family [43]. Besides the N terminus and G80) after strand 1 makes the backbone van der
Waals contacts to the AdoHcy homocysteine and aden-(see below), the only size differences between PRMT1
and PRMT3 are in the  barrel domain—a single-residue osine ribose moieties; (2) the acidic residue at the car-
boxyl end of strand 2 (E100) forms bifurcated hydrogendeletion in the loop between strands 10 and 11 and
an 8 residue insertion between strands 14 and 15 bonds with the ribose hydroxyl oxygens; and (3) the
acidic residue from the loop after strand3 (E129) hydro-(Figure 3B). The additional 8 residues near the C termi-
nus result in longer strands 14 and 15, while main- gen bonds with the amino group of adenine. These three
interactions are conserved among many structurallytaining the exact position of the carboxyl group COO
of the C-terminal residue next to the active site (Figure characterized consensus AdoMet-dependent methyl-
transferases, and define the structural context of the3B). Interestingly, the position of the carboxyl terminus
is also the same in the yeast RMT1 structure [44], which AdoMet/AdoHcy binding site [41, 42]. Unique interac-
tions for PRMT1 (and other members of the PRMT family)has an even larger insertion between strands 14 and
15 (see Figure 1A). This raises the possibility that the include H45 of helix Y (hydrogen bonding with one of
Table 2. Summary of X-Ray Data Collection and Model Refinement of PRMT1
Plasmid pXC248 pXC249 pXC252
Protein complex M11  AdoHcy S14  AdoHcy  R3 E153Q  AdoHcy  R1
Cell dimensions (A˚) 88.3 	 88.3 	 145.1 86.5 	 86.5 	 142.4 87.8 	 87.8 	 144.6
Resolution limit (A˚) 2.50 2.35 2.64
Completeness (%) 98.6 96.3 99.8
Rlinear 0.100 0.037 0.084

I/(I) 19.2 20.7 20.8
Observed reflections 102,483 77,491 116,340
Unique reflections 20,200 22,428 17,213
Rvalue 0.199 0.195 0.186
Rfree 0.263 0.254 0.249
PDB 1ORI IOR8 1ORH
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Figure 3. Structure of PRMT1
(A) Two views (top and bottom panels) of monomer structure. The N-terminal helix Y is shown in red, and the AdoMet binding domain in
green. The bound AdoHcy is shown in a stick model with the sulfur atom (where the transferable methyl group would be attached in AdoMet)
shown in yellow. The  barrel structure is shown in yellow, and the dimerization arm (which is inserted into the  barrel) is in light blue (see
Figure 1A). The bound arginine (blue) in the S14-AdoHcy-R3 ternary complex defines the active site, located between the AdoMet binding
domain (green) and the  barrel (yellow).
(B) Superposition of PRMT1 (residues 41–353, colored according to Figure 1A) and PRMT3 core (residues 208–528, in gray). Besides deletion
or insertion (located in loops between 10 and 11 and between 14 and 15), the two structures can be superimposed with less than 1 A˚
of root-mean-square deviation between them.
the ribose hydroxyl oxygens), R54 of helix Z (bridging 1) indeed reduced cofactor crosslinking (Figure 2D, lane
4) and abolished enzymatic activity (Figure 2A, lanes 9the carboxylate groups of the AdoHcy homocysteine
moiety and the active site residue E144), and flanking and 10), suggesting important roles of helix X both in
cofactor binding and catalysis.contacts to the AdoHcy adenine ring by C101 (after
strand 2) and M155 and T158 (loop after strand 4).
The N-terminal region helps to constrain the bound PRMT Dimerization Is Essential for AdoMet
Binding and Enzymatic ActivityAdoHcy. As noted above, the first 40 residues are neither
conserved at the sequence level nor observed in the A hydrophobic dimer interface (Figure 5) identical to that
of the PRMT3 core [43] and yeast RMT1 [44] is observedthree structures, though in M11, residual density can
be traced back to amino acid 36. In PRMT3 [43], an in PRMT1, despite very different crystallization condi-
tions, space group, and cell dimensions. This observa-additional N-terminal helix X was observed (Figures 1A
and 3B). Without helix X, the bound AdoHcy in PRMT1 tion supports the notion that dimer formation is a con-
served feature in the PRMT family [43]. A mutant ARMappears more exposed to solvent. Helix X contains
3 residues (YFxxY) invariant among all known PRMTs that lacks the entire dimerization arm (residues 188–222)
was generated. The purified ARM protein eluted as a(Figure 1A), including F218 in PRMT3 that forms an edge-
to-face hydrophobic interaction with the adenine ring 37 kDa monomer protein from a gel filtration column
(Table 1). TheARM mutant completely lacks enzymaticof AdoHcy, and Y217 and Y221, whose hydroxyl groups
point to the active site residue E335 (Figure 4B) [43]. In activity (Figure 2A, lane 25), most likely because it is
unable to bind cofactor AdoMet as determined by UVPRMT1, deleting helix X (deletion mutant S38 in Table
Structure
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Figure 4. Stereo View of AdoHcy Binding
(A) In PRMT1, the difference electron density
map is contoured at 5.5. Dashed lines indi-
cate hydrogen bonds.
(B) In PRMT3 (PDB ID code 1F3J; [43]), the
corresponding N-terminal residues F218,
Y217, and Y221 (red) are not observed in the
PRMT1 structure.
crosslinking experiments (Figure 2C, and Figure 2D, lane been shown in vitro that PRMT6 forms dimethylarginine
in a processive manner [20]. It is conceivable that a ring-11). A similar mutant of yeast RMT1 that replaces the
arm with alanines also resulted in the loss of dimer like dimer could allow the product of the first methylation
reaction, monomethylarginine, to enter the active siteformation and methylation activity [44]. In the crystal
structure, the dimer interface is formed between the arm of the second molecule of the dimer, without releasing
the substrate from the ring or replenishing the methyland the outer surface of the AdoMet binding site (Figure
5C). It is conceivable that the dimer interaction is re- donor.
In addition to the dimer interaction, we also observedquired to engage the residues on the other side of the
structural elements (Y-loop-Z and 1-loop-A) to in- a disulfide bond between C254 from strand 9 of two
crystallographically related molecules. This interactionteract with AdoMet properly.
Another potential function of the conserved PRMT caused PRMT1 dimers to form an extended polymer in
the crystal lattice (Figure 5A). The recombinant PRMT1dimer might be to allow processive production of the
final methylation product, asymmetric dimethylarginine. protein existed as an oligomer as judged by gel filtration
chromatography and dynamic light scattering (Table 1).PRMT substrates isolated in vivo are usually completely
or nearly completely dimethylated [3, 4, 45–47]. It has However, yeast RMT1 exists mainly as a dimer in solu-
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Figure 5. Dimer Formation of PRMT1
(A) Two ring-like dimers (related by a crystallographic 2-fold) connected by a surface C254 via a disulfide bond are shown with a difference
electron density map contoured at 5.5. The dimer is formed through the arm (blue) and the outer surface of AdoMet binding domain (green),
as indicated. The AdoHcy (gray) is in a stick model.
(B) Two opposite GRASP surfaces of PRMT1 dimer. The surface is colored red for negative, blue for positive, and white for neutral.
(C) Two opposite GRASP surfaces of PRMT1 monomer. Dimerization is mediated through hydrophobic patches of the arm and the outer
surface of AdoMet binding domain, as indicated.
tion but forms a hexamer (a trimer of three dimers) in The substrate binding surface of PRMT1 is expected
to be acidic, because most substrates for PRMT1 con-the crystal lattice [44]. We note that the higher order
tain multiple arginines. As shown in the surface chargeoligomerization does not occur in the absence of dimer-
distribution of PRMT1 dimer (Figure 5B), acidic residuesization (i.e., in the case of ARM). However, a C254S
are enriched on the inner surface of the dimer ring andmutant still forms oligomers similar to wild-type (Table
the outer surface of the  barrel. The structure of the1), and fully retains both cofactor binding (Figure 2D,
ternary S14-AdoHcy-R3 complex included electron den-lane 10) and methylation activity (Figure 2A, lane 24).
sities revealing the location of bound peptide ligandsThis is consistent with the fact that C254 is not com-
(Figure 6). However, the densities were broken into threepletely conserved among PRMT1s. Either the C254 di-
separate peptide fragment binding sites (P1, P2, andsulfide bond does not contribute to oligomerization of
P3), and, except for the arginine in the active site, thePRMT1 in solution and is unique to the crystal lattice, or
side chain densities were not sufficiently resolved tothe disulfide bond is one of several redundant stabilizing
allow clear identification of the amino acids. In compari-contacts.
son, no density was observed in any of the three P sites
in the structure of M11-AdoHcy without peptide.
Substrate Binding Surface The three disconnected densities probably represent
The peptides that contain one or three copies of the a mixture of binding modes of R3 peptide, which con-
consensus RGG repeat sequence (R1 or R3, respec- tains three potential methylation targets at positions 3,
tively) were cocrystallized with PRMT1. As shown in 9, and 15. Sites P1 and P2 correspond to the acidic
Figure 2B, the R3 peptide is a very good substrate for grooves in the interface between the two domains (green
PRMT1 (lanes 7–11) and competes with a protein sub- and yellow in Figure 6B). P1 is along the edge of helices
strate hnRNP A1 effectively (lanes 1–6). In contrast, the Y (red) and Z (green) and next to strand 11 and the
R1 peptide competes poorly with hnRNP A1 (lanes 12– THW loop (Figure 6B). P2 is flanked by helix D (green)
17), and was barely methylated under similar conditions and the short 310 helix I as well as the loop between
13 and 14 (yellow). If the central Arg9 were the target(data not shown).
Structure
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Figure 6. Structure of Ternary Complex of S14-AdoHcy-R3 Peptide (Sequence Shown at the Top)
(A) Solvent-accessible molecular surface with bound AdoHcy and Arg shown as stick models and indicated by the arrows. In the absence of
helix X (see Figure 3B), which is disordered in the PRMT1 crystals, AdoHcy is exposed and readily visible. The three discontinuous peptide
binding sites P1, P2, and P3 are shown as green tubes.
(B) Ribbon representation of (A) with the three peptide binding sites shown as annealed omit electron densities (black) contoured at 5.0.
Some of the structural elements flanking sites P2 and P3 are labeled.
(C) A 90 rotation of (B) showing that the binding sites P1 and P2 can be connected so that the middle Arg9 of peptide R3 is bound at the
active site.
(D) Two side views of (A) showing the three peptide binding sites as well as other acidic grooves parallel to P3 (indicated by the arrows). The
acidic residues flanking these grooves are labeled. In the left panel, it can be seen that connecting P2 and P3 would place the terminal
arginine (Arg3 or Arg15) at one end of P2 in the active site.
bound in the active site, connecting peptide binding structure), respectively. It is conceivable that the rest
of the N-terminal sequences differing among PRMT1sites P1 and P2 would cover the active site and the
entire length of the peptide (Figure 6C). The densities splicing variants could also be in the vicinity to contact
the protein substrate occupying the P2 binding groove,immediately around the active site arginine are not ob-
served, and the gaps account for the two glycines flank- consistent with the observation that PRMT1 splicing
variants have different substrate specificity [40].ing the arginine. Due to the ambiguous nature of the
density, the peptide can be fitted equally well in either Site P3 corresponds to one of the grooves (Figure 6D)
perpendicular to the sheet formed by  strands 9, 13,linear orientation. The acidic grooves containing P1 and
P2 are almost parallel to the N-terminal helices Y (Fig- 14, and 15 (see Figure 3A). When the end arginine (either
Arg3 or Arg15) is bound in the active site, connectionure 6B) and X (if present analogously to the PRMT3
PRMT1 Structure
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Figure 7. Active Sites of PRMT1 and PRMT3
(A) PRMT1 active site with bound Arg in stereo. The annealed omit electron density map, contoured at 5.0 of the arginine, is shown as an
insert.
(B) Superimposition of PRMT1 and PRMT3 (PDB ID code 1F3J) active sites in stereo. Only the PRMT3 residues are labeled. The arrow indicates
transfer of the methyl group (attached to AdoHcy) to the bound Arg.
(C) pH dependence of PRMT1 and PRMT3 activities. Reactions (20 l) contained 5 M of purified hnRNP A1 or 100 M of R3 peptide, 10
g/ml of PRMT1 or 50 g/ml of PRMT3200, 40 M [methyl-3H]AdoMet (0.5 Ci) in 100 mM buffer, 200 mM NaCl, 2 mM EDTA, and 1 mM
dithiothreitol. The buffers used were sodium acetate (pH 4 and 5), MES (pH 6.0, 6.3, 6.5, and 6.8), HEPES (pH 7.0 and 7.5), Tris (pH 8.0 and
8.5), and glycine (pH 9.0, 9.5, and 10.0). After incubating at 37C for 15 min, 2.5 l of 100 mg/ml BSA was added, followed by 0.5 ml of 20%
TCA. The samples were filtered and washed three times with 20% TCA through a GF/F filter (Millipore), dried, and subjected to liquid scintillation
counting.
of peptide binding sites P2 and P3 would account for no density was observed in the active site or the peptide
binding sites P1 and P2 in the structure of the E153Q-the length of the whole peptide (Figure 6D). Additional
acidic grooves running parallel to site P3 can be identi- AdoHcy-R1 ternary complex. However, we did observe
residual, broken density in the peptide binding site P3fied. These grooves could form additional binding sites
for protein substrate with more RGG repeats. (not shown), which is away from the active site. Perhaps
the preferential binding to this nonproductive site is theIn the case of R1 peptide, which is a poor substrate,
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cause for R1 peptide being a poor substrate. Alterna- Biological Implications
tively, E153Q mutation could prevent stable binding of
the peptide in the active site. We have described the crystal structures of the predom-
inant protein arginine methyltransferase PRMT1, in the
presence of methylation product AdoHcy and/or theActive Site
The target arginine is situated in a deep pocket between peptide substrate containing either one or three target
arginines. PRMT1 forms a ring-like dimer essential forthe AdoMet binding domain and the  barrel domain
(Figure 6A). The residues that make up the active site are AdoMet binding and enzymatic activity. The structure
also reveals residues for catalysis (E153Q) and candi-conserved across the PRMT family, and form a hairpin
between strand 4 and helix D. This is called the “dou- date residues for substrate recognition along three
grooves (P1, P2, and P3). This structure provides usefulble-E loop” because it contains two invariant glutamates
(E144 and E153; Figure 1A). The hydrophobic methylene starting points to map residues important for the binding
of PRMT1 to its diverse protein substrates as well asgroups of the target arginine lie parallel to the plane of
the Y148 aromatic ring, while the side chain of E144 other binding partners.
and the main chain carbonyl oxygen of E153 hydrogen
bond the guanidino group (Figure 7A). Experimental Procedures
Surprisingly, the side chain of E153 points away from,
Protein Expression and Purificationrather than toward, the bound guanidino group in the
Rat PRMT1 gene was subcloned from the original GST-PRMT1 con-active site. We noted that all three forms of PRMT1
struct [17] by PCR into a modified pET28b (Novagen) vector, which
were crystallized at low pH (4.7); under this condition adds a short N-terminal MGHHHHHH tag and accepts an NdeI-
PRMT1 is inactive (Figure 7C), perhaps due to proton- EcoRI insert. Deletions and point mutations were constructed by
PCR using the same vector. Cultures of E. coli strain BL21(DE3)ation of one or both Glu side chains. Consistent with
containing PRMT1 constructs were grown at 37C to OD600  0.4,the effects of protonation, E153Q mutation abolished
shifted to 22C, and induced by 0.4 mM IPTG overnight at 22C.methylation activity (Figure 2A, lane 16; Table 1),
The His-tagged proteins were purified using Ni-chelating, Mono Q,whereas the E153D mutation reduced the activity to
and Sephacryl S300 columns (Amersham-Pharmacia). One hundred
about 0.03% (Figure 2A, lane 17; Table 1). Both E153 micromolar AdoHcy was incubated with the load samples of the
mutants (D and Q) oligomerized to about the same size Mono Q and S300 columns prior to chromatography. The proteins
were homogeneous as judged by overloaded SDS-PAGE stainedas the wild-type (Table 1), indicating that the mutations
with Coomassie blue and their concentrations were estimated bydid not affect the overall structural integrity of the pro-
OD280 absorption using a calculated extinction coefficient of 52,090tein. On the other hand, regarding the second glutamate
M1cm1.in the double-E loop, both E144 mutants (particularly
Nontagged proteins were expressed using vector pET29b (Nova-
E144Q) are more aggregated (Table 1), suggesting that gen). The proteins were purified using two consecutive runs of Hitrap
the mutations may cause some structural perturbation Q column, a Resource Q column, a 200HR Sephadex or S300 Sepha-
cryl gel filtration column, followed by a Mono Q column (all Amer-by interrupting E144-R54 interaction (Figures 4A and
sham-Pharmacia). During early steps of purification, PRMT activity7A), and the activities of E144Q and E144D mutants
using hnRNP A1 as substrate was determined. The full-length pro-were reduced by 3000- and 10-fold, respectively (Figure
tein without tag and the S14 with His tag were both expressed poorly2A, lanes 18–20; Table 1). This strongly suggests that
in E. coli (
20% of the others) for unknown reasons, although the
the negative charges on both E153 and E144 are critical majority of all expressed proteins was soluble. For comparison, the
for catalysis, while the length of the side chain (Glu vs. yield of full-length protein (plasmid pXC246) was about 0.4 mg/L
with a final purity of about 80%, while the yield of the M11 deletionAsp) is also important.
mutant (plasmid pXC247) was about 4 mg/L and 95% pure asWe superimposed the active site residues of PRMT1
judged by SDS-PAGE.onto PRMT3, which was crystallized at pH 6.3 [43]
where PRMT3 has detectable activity (Figure 7C). As
PRMT Activity Assay, UV Crosslinking, and Oligomerizationshown in Figure 7B, the largest deviation is between
PRMT activity was assayed as described [43]. For UV crosslinking,E153 and S154 of PRMT1 and the corresponding resi-
20 l of PRMT1 (1–5 g) was incubated with 0.5 Ci of [methyl-
dues E335 and S336 of PRMT3. The superimposition 3H]AdoMet (78 Ci/mmol, NEN NET155H) overnight at 4C. Samples
placed the target arginine in between E326 and E335 of were added to a 96-well plate and placed 8 cm from an upside-
down UV transilluminator (VWR, 302 nm) for various times. ThePRMT3; the side chain of E335 could form a bifurcated
proteins were then separated by SDS-PAGE, stained with Coomas-hydrogen bond with the guanidino group (Figure 7B). A
sie blue, and subjected to fluorography.network of charge-charge interactions involving E335,
The protein size (oligomerization) was determined by gel filtrationthe target arginine, E326, R236, and the AdoHcy carbox-
chromatography on a Sephacryl S300 column using proteins (0.5
ylate would place the target nitrogen atom and the sulfur mg/ml) preincubated with AdoHcy. The column buffer contained 20
atom of AdoHcy into close proximity (shown by an arrow mM Tris (pH 8.0), 250 mM NaCl, 1 mM EDTA, 0.1% 2-mercaptoetha-
in Figure 7B). It has been proposed that the interaction nol, and 5% glycerol. Size was estimated based on a standard
run under the same buffer condition. The protein size was alsowith E335 of PRMT3 (equivalent to E153 of PRMT1)
determined by dynamic light scattering using DynaPro Molecularredistributes the positive charge on the guanidino group
Sizing Instrument (Protein Solutions), at 1 mg/ml of protein concen-toward one amino group while leaving a lone pair of
tration. The size shown in Table 1 was calculated with a regulariza-
electrons on the other amino group to attack the cationic tion model.
methylsulfonium moiety of AdoMet [43]. The corre-
sponding mutant of this residue in CARM1 (E267Q) has
Crystallography
been used to demonstrate that the methyltransferase The proteins were concentrated to about 20 mg/ml in the gel filtration
activity of CARM1 was required for synergy among nu- column buffer with 600 M of AdoHcy. Crystals were obtained via
the hanging drop method, with the mother liquor containing 100clear receptor coactivators [48].
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